Atara Biotherapeutics, Inc. (ATRA)
8.87
+0.53
(+6.35%)
USD |
NASDAQ |
May 11, 16:00
9.50
+0.63
(+7.10%)
After-Hours: 18:06
Atara Biotherapeutics Total Assets (Quarterly) : 21.89M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Savara, Inc. | 253.44M |
| Biogen, Inc. | 29.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.39M |
| Shareholders Equity (Quarterly) | -38.50M |
| Debt to Equity Ratio | -1.371 |
| Current Ratio | 0.8184 |
| Net Debt Paydown Yield | 5.33% |